drug
elagolix sodium
Marketedupdated 3mo agoby $ABBV AbbVie Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- tagApproval38 co-mentions · 12 sources
- drugORILISSA33 co-mentions · 12 sources
- tagSmall Molecule19 co-mentions · 12 sources
- drugORIAHNN (COPACKAGED)10 co-mentions · 5 sources
- drugelagolix sodium + estradiol + norethindrone + elagolix sodium5 co-mentions · 5 sources
- drugESTRING5 co-mentions · 5 sources
- drugnorethindrone5 co-mentions · 5 sources
Small molecule drug with a maximum clinical stage of Approval, with an approval for endometriosis.
all catalysts(7)
approval · 7
Jul 23, 2018
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Aug 28, 2019
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Feb 1, 2021
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Feb 1, 2021
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Feb 1, 2021
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Jun 5, 2023
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Dec 17, 2025
approval
$ABBV249.46-0.54%
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 6, 2029
~2.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (13)
- Aug 27, 2040method-of-use (U-3654)US 11690845
- Aug 27, 2040method-of-use (U-3654)US 11690845
- Jul 23, 2039compositionUS 11542239
- Jul 23, 2039compositionUS 11542239
- Aug 20, 2038formulationUS 12102637
- Aug 20, 2038formulationUS 12102637
- Apr 19, 2038method-of-use (U-3653)US 11690854
- Sep 1, 2036method-of-use (U-2735)US 10537572
- Sep 1, 2036method-of-use (U-2850)US 10682351
- Mar 14, 2034method-of-use (U-3389)US 11344551
- Mar 14, 2034method-of-use (U-3672)US 11707464
- Jul 6, 2029compositionUS 74199832.9y
- Jul 6, 2029compositionUS 74199832.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that